News brief­ing: Ab­b­Vie and Roche's Ven­clex­ta scores an­oth­er FDA OK; Im­muno­Gen nabs Chi­na deal with $40M cash

Ab­b­Vie and Roche’s Ven­clex­ta has got­ten a new FDA thumbs up.

The pair an­nounced Mon­day that reg­u­la­tors have ap­proved the drug in com­bi­na­tion with azac­i­ti­dine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER